You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Susceptibilities of all 5160 included strains derived from Chinese IAIs from 2012 to 2014 to 12 tested antibiotics

From: Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients

  Percent Susceptibilities
2012 2013 2014 Sum
Amikacin 87.20 89.16 86.22 87.53
Piperacillin Tazobactam 76.77 81.85 75.75 78.12
Ampicillin Sulbactam 18.70 24.72 23.30 22.24
Imipenem 80.66 84.26 79.30 81.41
Ertapenem 73.18 75.71 70.48 73.12
Cefoxitin 50.00 55.52 52.38 52.64
Ceftazidime 54.80 61.77 59.69 58.75
Cefepime 43.67 51.92 51.05 48.88
Ceftriaxone 31.25 36.74 38.66 35.55
Cefotaxime 30.98 36.49 37.46 34.98
Levofloxacin 49.63 53.90 55.62 53.05
Ciprofloxacin 45.52 48.20 50.35 48.02